McLachlan K A, Boston R, Alford F P
Department of Endocrinology and Diabetes, St Vincent's Hospital, Fitzroy, Australia.
Diabetologia. 2005 Jul;48(7):1373-9. doi: 10.1007/s00125-005-1775-6. Epub 2005 Jun 7.
AIMS/HYPOTHESIS: Non-esterified fatty acids are implicated in the pathogenesis of gestational (GDM) and type 2 diabetes. We examined the relationship between NEFA dynamics, insulin resistance and beta cell dysfunction in women with GDM in late pregnancy and postpartum.
A total of 19 Caucasian women with GDM and 19 healthy pregnant women matched for BMI and age underwent an IVGTT in the third trimester and 4 months postpartum, deriving values for insulin sensitivity (SI), insulin secretion (AIRg) and disposition index (DI). NEFA levels were measured serially.
In pregnancy, the GDM women had similar SI but reduced AIRg and DI compared with control subjects. The GDM group demonstrated significantly slower NEFA suppression, which was attributable to the GDM women who required insulin during pregnancy (n=7) and who had markedly reduced AIRg and K(NEFA) (NEFA disappearance constant) compared with their matched controls. In contrast, GDM subjects not requiring insulin (n=12) had similar NEFA suppression curves and AIRg to control subjects. Postpartum, GDM subjects demonstrated reduced SI and DI. The impaired suppression of NEFA persisted postpartum, but again only in the subgroup of GDM subjects who had required insulin during pregnancy. Furthermore, K(NEFA) correlated with AIRg and DI in both states, but not with SI.
CONCLUSIONS/INTERPRETATION: Impaired NEFA suppression occurs in GDM subjects both in late pregnancy and postpartum in response to IVGTT-induced endogenous insulin secretion. The impaired NEFA suppression is present in GDM women with the most severe beta cell dysfunction (who had required insulin during pregnancy) and is related to their insulin secretory dysfunction rather than their reduced SI.
目的/假设:非酯化脂肪酸与妊娠期糖尿病(GDM)和2型糖尿病的发病机制有关。我们研究了妊娠晚期和产后患有GDM的女性中,非酯化脂肪酸(NEFA)动态变化、胰岛素抵抗和β细胞功能障碍之间的关系。
共有19名患有GDM的白种女性和19名体重指数(BMI)及年龄匹配的健康孕妇在孕晚期和产后4个月接受了静脉葡萄糖耐量试验(IVGTT),得出胰岛素敏感性(SI)、胰岛素分泌(AIRg)和处置指数(DI)的值。连续测量NEFA水平。
在孕期,与对照组相比,患有GDM的女性SI相似,但AIRg和DI降低。GDM组的NEFA抑制明显较慢,这归因于孕期需要胰岛素治疗的GDM女性(n = 7),与匹配的对照组相比,她们的AIRg和K(NEFA)(NEFA消失常数)明显降低。相比之下,不需要胰岛素治疗的GDM受试者(n = 12)的NEFA抑制曲线和AIRg与对照组相似。产后,GDM受试者的SI和DI降低。NEFA抑制受损在产后持续存在,但同样仅在孕期需要胰岛素治疗的GDM亚组中出现。此外,K(NEFA)在两种状态下均与AIRg和DI相关,但与SI无关。
结论/解读:在妊娠晚期和产后,GDM受试者在IVGTT诱导内源性胰岛素分泌时出现NEFA抑制受损。NEFA抑制受损存在于β细胞功能障碍最严重的GDM女性中(孕期需要胰岛素治疗),并且与她们的胰岛素分泌功能障碍有关,而非与SI降低有关。